Patents by Inventor Katsukuni MITSUI

Katsukuni MITSUI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prophylactic and/or therapeutic agent for fibromyalgia
    Patent number: 10675275
    Abstract: (1S)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[?-carboline-4,1?-cyclopropane] can significantly suppress a decrease of a pain threshold compared to well-known TSPO antagonists, and thus can be an excellent prophylactic and/or therapeutic agent for fibromyalgia, fibromyalgia-associated diseases, and fibromyalgia-associated symptoms.
    Type: Grant
    Filed: January 8, 2016
    Date of Patent: June 9, 2020
    Assignee: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Seishi Katsumata, Katsukuni Mitsui, Yuya Ezaki
  • PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR FIBROMYALGIA
    Publication number: 20180169077
    Abstract: (1S)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[?-carboline-4,1?-cyclopropane] can significantly suppress a decrease of a pain threshold compared to well-known TSPO antagonists, and thus can be an excellent prophylactic and/or therapeutic agent for fibromyalgia, fibromyalgia-associated diseases, and fibromyalgia-associated symptoms.
    Type: Application
    Filed: January 8, 2016
    Publication date: June 21, 2018
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Seishi KATSUMATA, Katsukuni MITSUI, Yuya EZAKI
  • MEDICAMENT FOR PREVENTING AND/OR TREATING STRESS DISEASES
    Publication number: 20170119742
    Abstract: The present invention relates to a medicament for preventing and/or treating stress diseases, said medicament being characterized in that (1S)-2-acetyl-1-(4-chloro-2-methoxyphenyl)-5-fluoro-1,2,3,9-tetrahydrospiro[?-carboline-4,1?-cyclopropane] is administered at such a specific dose that a brain TSPO occupancy requiring for expressing the pharmacological effects of the medicament can be obtained.
    Type: Application
    Filed: June 11, 2015
    Publication date: May 4, 2017
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Seishi KATSUMATA, Katsukuni MITSUI